Literature DB >> 28805780

[Regional and peripheral blockades for prevention of chronic post-thoracotomy pain syndrome in oncosurgical practice].

V E Khoronenko1, A S Malanova1, D S Baskakov1, A B Ryabov1, O V Pikin1.   

Abstract

AIM: To compare an effectiveness of thoracic epidural anesthesia/analgesia, paravertebral and intercostal blockades in prevention of chronic post-thoracotomy pain syndrome (CPTPS) in oncosurgery.
MATERIAL AND METHODS: There were 300 patients who underwent open surgery including lobectomy or pneumonectomy. Patients were randomized into 3 groups depending on type of anesthesia: TEA (n=100) - combined general and epidural anesthesia; PVB (n=50) - combined general and paravertebral anesthesia; ICB (n=50) - general anesthesia was supplemented by intercostal blockade after removal of the drug.
RESULTS: CPTPS incidence was 34 and 40% in 6 months postoperatively after PVB and ICB, respectively (p>0.05). In TEA group this value was significantly lower compared with ICB group (23%, p<0.05).
CONCLUSION: TEA contributes to significant reduction of CPTPS incidence, while paravertebral blockade does not affect the frequency of this complication.

Entities:  

Keywords:  chronic post-thoracotomy pain syndrome; regional and peripheral blockades

Mesh:

Substances:

Year:  2017        PMID: 28805780     DOI: 10.17116/hirurgia2017858-63

Source DB:  PubMed          Journal:  Khirurgiia (Mosk)        ISSN: 0023-1207


  2 in total

1.  Influence of Regional Anesthesia on the Rate of Chronic Postthoracotomy Pain Syndrome in Lung Cancer Patients.

Authors:  Victoria Khoronenko; Danil Baskakov; Marc Leone; Anna Malanova; Andrey Ryabov; Oleg Pikin; Maksim Golovashchenko
Journal:  Ann Thorac Cardiovasc Surg       Date:  2018-06-20       Impact factor: 1.520

2.  Effects of thoracic epidural anesthesia/analgesia on the stress response, pain relief, hospital stay, and treatment costs of patients with esophageal carcinoma undergoing thoracic surgery: A single-center, randomized controlled trial.

Authors:  Yan Li; Hongquan Dong; Shanbai Tan; Yanning Qian; Wenjie Jin
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.